Net Income

Vanguard Canada projects zero capital gains distributions for three key bond ETFs, offering investors a tax reprieve and a signal on the 2025 market.

As air traffic control migrates to VoIP, new testing solutions ensure the reliability and interoperability crucial for preventing communication failures.

Incyte's Minjuvi, a first-of-its-kind immunotherapy, gains EC approval for follicular lymphoma, offering patients a powerful new chemo-free option.

As the market for oral supplements explodes, products like Synadentix promise a healthier mouth. But does the science back the billion-dollar marketing?

Leading wellness franchise Prime IV Hydration & Wellness lands major financing to accelerate its rapid expansion in the booming IV therapy market.

Iconic Ohio-based Donatos Pizza is coming to Houston, bringing its Edge to Edge® pies into one of America's most competitive pizza scenes.

Former IBERIABANK CEO Daryl Byrd is back, leading a $250M investment to transform M C Bank into a regional powerhouse. Here’s what it means for Louisiana.

SCWorx Corp. has signed a new agreement with a 500-bed academic hospital, highlighting the critical need for clean data in complex Workday ERP systems.

A new survey reveals 88% of finance leaders see AI as transformative, yet few are prepared, highlighting an urgent need for upskilling to close the gap.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

How decades-old industrial equipment is challenging modern concepts of value, forcing a re-evaluation of sustainability and long-term investment strategy.

After 40 years, CEO Michael Magnavita will retire in 2026. Internal successor Drew Stanley is set to lead the award-winning institution's next chapter.

YXT.com's $100M shelf registration gives it a war chest for AI growth, but investors weigh the promise of innovation against current financial pressures.

A key trial update de-risks Tenax Therapeutics' pivotal study for a novel heart failure therapy, boosting confidence in its path to market.

A historic shift is underway in Canada's rental market. Slowing immigration and a construction boom are creating a surplus, giving tenants unprecedented choice.

With a fresh $35M led by CVS Health Ventures, Codoxo's generative AI platform aims to stop costly healthcare payment errors before they even happen.

Amid a lagging stock price, Western Uranium & Vanadium is launching a significant share buyback, signaling deep confidence in its undervalued assets.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.

UWM Holdings is acquiring Two Harbors in a $1.3B all-stock deal, nearly doubling its MSR portfolio in a bold move to create a mortgage powerhouse.